Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formationHide this content
Distribution Data
US Market Release
2015-09-11
CE Approval Date
2014-03-31
Registered USA Implants
8338
Estimated Active USA Implants
6789
Normal Battery Depletions
4
US Market Release
2015-09-11
CE Approval Date
2014-03-31
Estimated WW Distribution
61202
Normal Battery Depletions
5
Malfunctions (USA)
Therapy Function Not Compromised
4
Battery
2
Electrical Component
2
Therapy Function Compromised
3
Battery
2
Electrical Component
1
Malfunctions (WW)
Therapy Function Not Compromised
35
Battery
20
Electrical Component
13
Other
2
Therapy Function Compromised
20
Battery
14
Electrical Component
6
EOS Indication
From the point that the RRT is set, the
pacemaker will operate for approximately
three months for typical pacemaker
configurations during the normal
operating life.
Recommended Replacement (RRT)
Battery voltage less than 2.73V on 3
consecutive daily automatic
measurements.
